- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03946020
GBR and Autogenous Bone Chips
Bovine Derived Xenograft in Combination With Autogenous Bone Chips Versus Xenograft Alone for the Augmentation of Bony Dehiscences Around Oral Implants: a Randomized, Controlled, Split-mouth Clinical Trial
This study will be an open, prospective, split-mouth, randomised controlled clinical trial. A total of 14 patients searching for oral implant treatment and where a GBR procedure is indicated per implant treatment will be enrolled.
All patients have to fulfill all of the inclusion criteria and none of the exclusion criteria. From all patients clinical photos will be taken.
Two sites within a patient will be randomly allocated to the 'autologous bone chips and DBBM or 'DBBM particles alone' group.
The study will be 1 year follow-up study comprising 9 visits
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A randomized controlled clinical trial (RCT) to compare the use of deproteinized bovine bone mineral (DBBM) in combination with autogenous bone chips versus a DBBM alone for the augmentation of bony dehiscence after dental implant placement
Objectives: 1. To test whether the use of DBBM is not inferior to the use of a combination of DBBM and autogenous bone chips for the filling of bony dehiscence around dental implants
2. To test whether a digital impression technique can be used to measure guided bone regeneration in comparison to conventional measurement with a dental probe and to compare these observations with cone beam CT images
Study Design: Randomized, controlled, single center, split mouth study
Study Population: Partially edentulous male or female patients in need for oral implants for a fixed prosthetic implant supported rehabilitation and where a Guide Bone Regeneration (GBR) procedure is indicated during implant treatment
Patient Number: 14
Duration of treatment: The time in the study for each patient will be 1 year and 4 months. The treatment period includes implant and abutment installation (in a twostage procedure), with a healing time of minimum 12 weeks before the start of the prosthetic phase.
Study devices: Implants: 3.3 / 4.1 / 4.8 mm Straumann Bone level implants Bone Graft: DBB (Demineralised Bovine Bone, Bio OSS) Measuring Devices: Cadent iTero & software and Dental Probes Prosthetics: Straumann (computer aided design computer aided manufacturing (CAD CAM) crowns and abutments
Outcome variables:
Primary outcome variable: Difference in bone fill between DBB + bone chips vs. DBB without bone chips afer 24 weeks of submerged healing. The "ideal bone volume" as defined at base line (= 100%) will be compared to the received bone fill [%] at re-entry measured by a digital impression technique (before and after GBR, and at abutment connection, before and after raising a flap, and at the 1-year follow-up).
The method of digital impression will be compared to CBCT immediately after implant placemetn and 1 year and periodontal probing during surgery and re-enty
Secondary Parameters:
Page 5 of 35 A comparison of 3 different tools (probe, CBCT and digital impression) for measuring the bone volume changes in relation to GBR procedures. Implant survival en success rates on a patient and implant level Marginal bone level alterations
Safety: Adverse Events / Adverse Device Effects
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- > 18 years,
- in need of a solitary implant in quadrant 1 and 2 or quadrant 3 and 4 with simultaneous GBR procedure
- presence of a pre-operative CBCT.
Exclusion Criteria:
- smokers
- patients with systemic diseases that could interfere with the healing
- patients undergoing bisphosphonate treatment
- patients who previously received radiation therapy of the jaws
- patients that received a GBR procedure in the region of interest in the past.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Augmentation with autologous bone + DBBM
A layer of autogenous bone chips was placed on the implant surface.
On top of this a layer of DBBM (Bio-Oss™, Geistlich®, Wolhusen, Switserland) was placed, thereafter covered with a collagen membrane.
|
Autogenous bone chips were collected.
On each side a bone level implant was placed.
The bone dehiscence was measured and was thereafter treated according to the GBR protocol.
A resorbable native collagen was adapted to the defect.
|
Experimental: Augmentation with DBBM
A layer of DBBM was placed on the implant surface and thereafter covered with a collagen membrane.
Care was taken to make both augmentations as comparable as possible by weighting the used amount of graft material.
|
Autogenous bone chips were collected.
On each side a bone level implant was placed.
The bone dehiscence was measured and was thereafter treated according to the GBR protocol.
A resorbable native collagen was adapted to the defect.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Horizontal and vertical bone augmentation
Time Frame: 16 weeks
|
The change of dimension was assessed comparing Cone Beam Computed Tomography scans (CBCT)
|
16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Success of grafting procedure as assessed by clinical interpretation
Time Frame: 1 year
|
Defined as no persistent pain in the grafted area and no suppuration or expulsion of graft material and implant survival rates being lack of mobility, absence of peri-implant radiolucency, absence of recurrent peri-implant infection with suppuration, absence of continuous or recurrent pain, and no structural failure of the implant
|
1 year
|
Marginal bone level alterations assessed on peri-apical radiographs using software (ImageJ)
Time Frame: 1 year
|
measured from a reference point (implant shoulder) to the most coronal point of BIC, both mesially and distally
|
1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Andy Temmerman, DDS, MSc, PhD, Universitaire Ziekenhuizen KU Leuven
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- S55609
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bone Resorption
-
Cairo UniversityUnknown
-
Second Affiliated Hospital, School of Medicine,...RecruitingAlveolar Bone ResorptionChina
-
Aristotle University Of ThessalonikiUniversity Paul Sabatier of ToulouseRecruiting
-
Nourhan M.AlyAlexandria UniversityCompletedMandibular Bone ResorptionEgypt
-
Marmara UniversityCompleted
-
Egyptian Russian UniversityCompletedAlveolar Bone ResorptionEgypt
-
Cairo UniversityUnknown
-
International Advanced Dentistry, LisbonUnknownBone Loss | Alveolar Bone Resorption
-
University of LouisvilleBioHorizons, Inc.RecruitingAlveolar Bone ResorptionUnited States
-
Universitaire Ziekenhuizen KU LeuvenCompleted
Clinical Trials on Guided bone regeneration with or without autologous bone
-
The University of Texas Health Science Center at...CompletedFractured Tooth | Missing Tooth
-
Urban Regeneration InstituteSzeged UniversityCompletedDental Implants | Bone Regeneration | PolytetrafluoroethyleneHungary
-
BiomatlanteAtlanstatUnknownPeriodontal Bone Loss | Alveolar Bone Loss | Oral Bone Defect | Maxillofacial Bone DefectFrance
-
University of Sao PauloCompletedPeriodontal Diseases | Bone DiseasesBrazil
-
Fernanda Vieira RibeiroUnknown
-
University of ZurichInion OyCompletedBone Regeneration Following Wisdom Teeth ExtractionSwitzerland
-
Queen Mary University of LondonUniversity of ZurichRecruitingBiomarkers | Dental Implant | Saliva | Guided Bone RegenerationUnited Kingdom
-
Queen Mary University of LondonUniversity of ZurichNot yet recruitingHealing Wound | Biomarkers | Dental Implant | SalivaUnited Kingdom
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed